Abstract
Type A botulinum neurotoxin is one of the most lethal of the seven serotypes and is increasingly used as a therapeutic agent in neuromuscular dysfunctions. Its toxic function is related to zinc-endopeptidase activity of the N-terminal light chain (LC) on synaptosome-associated protein-25 kDa (SNAP-25) of the SNARE complex. To understand the determinants of substrate specificity and assist the development of strategies for effective inhibitors, we used site-directed mutagenesis to investigate the effects of 13 polar residues of the LC on substrate binding and catalysis. Selection of the residues for mutation was based on a computational analysis of the three-dimensional structure of the LC modeled with a 17-residue substrate fragment of SNAP-25. Steady-state kinetic parameters for proteolysis of the substrate fragment were determined for a set of 16 single mutants. Of the mutated residues non-conserved among the serotypes, replacement of Arg-230 and Asp-369 by polar or apolar residues resulted in drastic lowering of the catalytic rate constant (k cat), but had less effect on substrate affinity (K m). Substitution of Arg-230 with Lys decreased the catalytic efficiency (k cat/K m) by 50-fold, whereas replacement by Leu yielded an inactive protein. Removal of the electrostatic charge at Asp-369 by mutation to Asn resulted in 140-fold decrease in k cat/K m. Replacement of other variable residues surrounding the catalytic cleft (Glu-54, Glu-63, Asn-66, Asp-130, Asn-161, Glu-163, Glu-170, Glu-256), had only marginal effect on decreasing the catalytic efficiency, but unexpectedly the substitution of Lys-165 with Leu resulted in fourfold increase in k cat/K m. For comparison purposes, two conserved residues Arg-362 and Tyr-365 were investigated with substitutions of Leu and Phe, respectively, and their catalytic efficiency decreased 140- and 10-fold, respectively, whereas substitution of the tyrosine ring with Asn abolished activity. The altered catalytic efficiencies of the mutants were not due to any significant changes in secondary or tertiary structures, or in zinc content and thermal stability. We suggest that, despite the large minimal substrate size for catalysis, only a few non-conserved residues surrounding the active site are important to render the LC competent for catalysis or provide conformational selection of the substrate.
Similar content being viewed by others
Abbreviations
- BoNT:
-
Botulinum neurotoxin
- LC:
-
Light chain
- SNAP-25:
-
Synaptosome-associated protein-25 kDa
- SNARE:
-
SNAP receptor
- WT:
-
Wild type
- DTT:
-
Dithiothreitol
References
Montecucco C, Schiavo G (1995) Q Rev Biophys 28:423–472
Schiavo G, Shone CC, Bennett MK, Scheller RH, Montecucco C (1995) J Biol Chem 270:10566–10570
Turton K, Chaddock JA, Acharya KR (2002) Trends Biochem Sci 27:552–558
Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O’Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K (2001) JAMA 285:1059–1070
Steinhardt RA, Bi G, Alderton JM (1994) Science 263:390–393
Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O’Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999) Neurology 53:1431–1438
Verheyden J, Blitzer A, Brin MF (2001) Semin Cutan Med Surg 20:121–126
Zhou L, de Paiva A, Liu D, Aoki R, Dolly JO (1995) Biochemistry 34:15175–15181
Ahmed SA, Byrne MP, Jensen M, Hines HB, Brueggemann E, Smith LA (2001) J Protein Chem 20:221–231
Jensen MJ, Smith TJ, Ahmed SA, Smith LA (2003) Toxicon 41:691–701
Breidenbach MA, Brunger AT (2004) Nature 432:925–929
Yamasaki S, Binz T, Hayashi T, Szabo E, Yamasaki N, Eklund M, Jahn R, Niemann H (1994) Biochem Biophys Res Commun 200:829–835
Rigoni M, Caccin P, Johnson EA, Montecucco C, Rossetto O (2001) Biochem Biophys Res Commun 288:1231–1237
Schmidt JJ, Bostian KA (1995) J Protein Chem 14:703–708
Schmidt JJ, Bostian KA (1997) J Protein Chem 16:19–26
Shone CC, Quinn CP, Wait R, Hallis B, Fooks SG, Hambleton P (1993) Eur J Biochem 217:965–971
Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC (1998) Nat Struct Biol 5:898–902
Lacy DB, Stevens RC (1999) J Mol Biol 291:1091–1104
Ahmed SA, Smith LA (2000) J Protein Chem 19:475–487
Ahmed SA, McPhie P, Smith LA (2003) Biochemistry 42:12539–12549
Laemmli UK (1970) Nature 227:680–685
Schagger H, von Jagow G (1987) Anal Biochem 166:368–379
Olson MA, Armendinger TL (2002) Protein Eng 15:739–743
Gilson MK, Honig B (1988) Proteins 4:7–18
Cornell WD, Cieplak P, Bayly CL, Gould IR, Merz KM Jr, Freguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA (1995) J Am Chem Soc 117:5179–5197
Jackson RM, Sternberg MJE (1994) Protein Eng 7:371–383
Auld DS (1995) Methods Enzymol 248:228–242
Kraulis PJ (1991) J Appl Cryst 24:946–950
Nicholls A, Sharp KA, Honig B (1991) Proteins: Struct Funct Genet 11:281–296
Swaminathan S, Eswaramoorthy S (2000) Nat Struct Biol 7:693–699
Arndt JW, Chai Q, Christian T, Stevens RC (2006) Biochemistry 45:3255–3262
Agarwal R, Eswaramoorthy S, Kumaran D, Binz T, Swaminathan S (2004) Biochemistry 43:6637–6644
Agarwal R, Binz T, Swaminathan S (2005) Biochemistry 44:11758–11765
Arndt JW, Yu W, Bi F, Stevens RC (2005) Biochemistry 44:9574–9580
Binz T, Bade S, Rummel A, Kollewe A, Alves J (2002) Biochemistry 41:1717–1723
Schmidt JJ, Stafford RG (2003) Appl Environ Microbiol 69:297–303
Li L, Singh BR (2000) Biochemistry 39:6466–6474
Chen S, Kim J-JP, Barbieri JT (2007) J Biol Chem 282:9621–9627
Fu Z, Chen S, Baldwin MR, Boldt GE, Crawford A, Janda KD, Barbieri JT, Kim JJ (2006) Biochemistry 45:8903–8911
Silvaggi NR, Boldt GE, Hixon MS, Kennedy JP, Tzipori S, Janda KD, Allen KN (2007) Chem Biol 14:533–542
Li L, Binz T, Niemann H, Singh BR (2000) Biochemistry 39:2399–2405
Miles EW, Kawasaki H, Ahmed SA, Morita H, Nagata S (1989) J Biol Chem 264:6280–6287
Acknowledgments
The research described herein was sponsored by JSTO-CBD (RIID 3.10012_06_RD_B to SAA and RIID 02-4-34-064 to LAS). We thank Dr. Charles Millard and Dr. Lou Carlacci for helpful comments, and Dr. James J. Schmidt for critical reading of the manuscript. Disclaimer: Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmed, S.A., Olson, M.A., Ludivico, M.L. et al. Identification of Residues Surrounding the Active Site of Type A Botulinum Neurotoxin Important for Substrate Recognition and Catalytic Activity. Protein J 27, 151–162 (2008). https://doi.org/10.1007/s10930-007-9118-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-007-9118-8